用药物治疗来解决阻塞性睡眠呼吸暂停:专家指导
Christian D Harding1, Ana Lucia Fuentes1,2, Atul Malhotra1
1Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of California San Diego (UCSD), La Jolla, CA, USA.
Expert opinion on pharmacotherapy
|June 24, 2024
概括
阻塞性睡眠呼吸暂停 (OSA) 的药物治疗为改善患者结果提供了一个有希望的途径. 药物可以减少呼吸暂停事件,管理过度白天嗜睡等症状,并提高对现有治疗方法的坚持.
科学领域:
- 药理学 药理学是指药理学的学科.
- 睡眠医学 睡眠医学
- 内部医学 内部医学
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 是一种普遍存在的疾病,具有显著的心脏代谢和神经认知健康风险.
- 已经建立了对OSA的非药物治疗方法,但药物可以进一步改善症状并减少副作用.
- 确定针对OSA的向药物治疗仍然是一个关键的研究目标.
研究的目的:
- 为了证明药物治疗在治疗阻塞性睡眠呼吸暂停时的必要性.
- 审查现有和潜在的药物类别用于OSA治疗.
- 突出药物治疗对那些不坚持传统治疗的患者的好处.
主要方法:
- 从2024年3月1日到2024年4月18日,PubMed数据库的文献综述.
- 确定针对呼吸暂停事件,症状缓解和治疗坚持的药物类别.
- 综合目前对OSA病理学和治疗剂识别的理解.
主要成果:
- 药物治疗可以通过减少呼吸暂停事件 (例如,减肥剂,通风激活剂,兴奋剂) 来准OSA.
- 药物可以缓解OSA症状,例如过度的白天嗜睡 (例如,唤醒促进剂).
- 像催眠药这样的药物可以改善对已建立的OSA治疗的坚持.
结论:
- 了解OSA病理学和药物发现技术的进步支持扩大药物治疗的使用.
- 药物治疗对阻塞性睡眠呼吸暂停的治疗提供了宝贵的补充.
- 有针对性的药物开发具有显著的潜力,可以改善OSA患者的治疗结果.
相关概念视频
01:21Sleep Apnea
143
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
143
01:19Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:23Sedatives and Hypnotics: Overview
336
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
336
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
168
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
168
01:17Sleepwalking and Sleep Talking
142
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
142